CD40mAb adjuvant induces a rapid antibody response that may be beneficial in post-exposure prophylaxis.
JOURNAL OF IMMUNE BASED THERAPIES AND VACCINES 2010;
8:1. [PMID:
20205811 PMCID:
PMC2824643 DOI:
10.1186/1476-8518-8-1]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/21/2009] [Accepted: 02/04/2010] [Indexed: 11/10/2022]
Abstract
Active vaccination can be effective as a post-exposure prophylaxis, but the rapidity of the immune response induced, relative to the incubation time of the pathogen, is critical. We show here that CD40mAb conjugated to antigen induces a more rapid specific antibody response than currently used immunological adjuvants, alum and monophosphoryl lipid A.
Collapse